NEW YORK (GenomeWeb) – Fitch Ratings today affirmed the ratings of Bio-Rad Laboratories, including the issuer default rating, at BBB- .

Additionally, Fitch assigned a BBB- rating to the firm's senior unsecured bank notes and its senior unsecured bank facility and said that Bio-Rad's rating outlook is stable.

The ratings apply to approximately $437 million of debt at Sept. 30, 2014.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.